MUNIT has announced it will be participating at the Formulation & Delivery Europe: Online Edition.
The event will take place from 20 – 21 April 2021 and includes:
Over 500 pharmaceutical scientists working across formulation, drug delivery and drug product manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally-renowned academic institutions;
Over 50 presentations and case studies focused on the crucial issues in solid state dissolution, novel therapeutic product development, drug delivery technologies and combination products.
PLUS Interactive opportunities including:
- Roundtable discussions
- Panel Discussions
- Pre-event podcasts and webinars
Please, find out more here: https://www.oxfordglobal.co.uk/formulation-delivery-series-uk-virtual/
MUNIT has announced that it will soon participate in the following event:
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology will be held as a virtual conference due to the SARS-CoV-2 pandemic in 2021.
This conference has gained an ever increasing impact among the pharmaceutical scientists: With more than 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
The entire spectrum of topics, ranging from engineering aspects during the manufacturing process, the portfolio of commercially available excipients enabling formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.
MUNIT has announced that it will soon participate in the following event:
Respiratory Drug Delivery 2021 (RDD 2021) is the must attend, premier international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery.
While the global pandemic is keeping us physically apart, RDD 2021 is evolving to bring us closer in a new virtual format. Gone are separate rooms for podium, workshop, exhibition and poster sessions. Welcome to on-screen Knowledge Spaces, where quality curated science and services are arranged by theme.
MUNIT has announced that it will soon participate in the following events:
This event will enable the participants to learn about the latest developments in the HPAPI Industry. This Summit will be focusing on latest market development trends in the highly potent active pharmaceutical ingredients, global standards, innovation challenges & expectations, sustainability, emerging markets, future trends & technological developments, etc.
Please book your participation now here: https://www.vonlanthenevents.com/en/6th-annual-highly-potent-active-pharmaceutical-ingredients-online-summit
The 2021 Virtual Summit (15-17 March 2021) covers both small molecules and biologics, new technologies, concepts and case studies in areas such as:
- Formulation design for poorly soluble compounds
- The potential of nanotechnology for better deliverability
- The latest controlled released technologies
- Improving patient compliance by harnessing data and the latest smart device technology
- Optimising formulations for continuous manufacturing
- Overcoming the blood brain barrier and challenges in oral delivery of biologics
- Reformulation and biosimilars
Global DDF Virtual includes 3 days of live and on-demand content. Hear expert speakers discuss vital developments and challenges live from anywhere in the world and participate via chats, polls and Q&As during each session.
Share your experiences in event group chats. Ask questions and discuss your needs with suppliers via direct messages. Discuss ideas with expert-speakers and the community in dedicated conference session chats.
MUNIT is participating at this years Global DDF Virtual Summit (15-17 March 2021) as a Commercial Partner.
For more information: https://www.ddfevent.com/
Book your place: https://www.ddfevent.com/book-your-place
We invite you to join us at DDL2020 – DDL is Europe’s premier conference dedicated to pulmonary and nasal drug delivery.
Due to the ongoing global pandemic the DDL2020 conference, which was due to take place in Edinburgh in December, will now be delivered virtually.
This year DDL2020 is online with live lectures, on-demand presentations, discussion forums and networking rooms.
DDL aim to deliver cutting edge science which is accessible to all and it’s pleased to offer FREE registration for online event for 2020.
Your registration for the DDL2020 Christmas Lectures includes:
-Access to the online virtual platform;
-LIVE presentations from invited speakers;
-FLASH presentations selected from submitted;
-Discussion forum to enable collaborative debate following the lectures;
-Access to the Exhibition Hall where you can video chat with exhibitors;
-Live Help desk.
Following the event, the online platform will remain live for 30 days, making it easy to catch up on anything you have missed.
All the live presentations will be recorded and available for the 30 days.
Please click here to complete your free registration!
The 9th edition of the Annual HPAPI Summit will be a virtual edition (100% online), 19-20 November 2020, 8.30am – 6pm EST.
Munit SA will represent its affiliates Jetpharma and Microchem: Register now and join the leading conference in the HPAPI arena.
As we return for our 9th year, the HPAPI Summit will focus on current market trends; including process development and scale-up, cost-effective production, containment innovations and best manufacturing practices as well as regulatory updates. Immerse yourself in this industry-led meeting where you will:
1. Understand your regulatory frameworks to ensure your manufacturing quality and environment are compliant
2. Gain clarity on how you can enhance every stage of your potent compound development strategy
3. Learn about process design and development from R&D to commercial manufacturing
4. Evaluate the latest technology advancements, from single use to containment to isolators – what are the most cost-effective solutions for your HPAPI molecules?
Interested in finding out more? Register now
Our 2020 conference is shaping up to be the most comprehensive event of the series to date. Here’s what you can expect:
Dedicated streams for Development and Manufacturing and EHS/Tox
Regulatory insight from the MHRA, European Commission and guidance on ANNEX 1 and ISPE Center of Practice (CoP) on Containment
A focus on scale up and coverage of bench, pilot and full-scale
Hours of virtual networking
MUNIT is participating at this years Formulation & Delivery Series UK (08 – 09 July 2020) with a Solution provider Showcase Presentation (“MICRONIZATION of Pharmaceutical Compounds”), a roundtable discussion (“Micronization of API’s and High Potent Materials for Inhalation Purpose, but not only…”) and a virtual booth.
For more information: https://www.oxfordglobal.co.uk/formulation-delivery-series-uk-virtual/
Welcoming over 250 key leaders, the Formulation & Drug Delivery Congress will discuss the state of the industry, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, as well as highlighting key updates in amorphous solid dispersions and combination products.
Munit will participate the Formulation and Drug Delivery Summit in San Diego (USA), 17th – 18th March 2020. We are looking forward seeing you at this event!
We announce our participation at the 11th Global Drug Delivery & Formulation Summit (March 9th – 11th 2020) in Berlin.
MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased to welcome you at our booth.
For more information, visit: www.ddfevent.com